Fibrinogen Testing Market
Fibrinogen Testing Market Study by Q.F.A. Thrombin Kits, Fibrinogen Kits, Multifibren U Kits, STA-fibrinogen Kits, and Imidazole Buffer Kits from 2024 to 2034
Analysis of Fibrinogen Testing Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Fibrinogen Testing Market Outlook (2024 to 2034)
The global fibrinogen testing market size is estimated to expand from US$ 209.7 million in 2024 to US$ 493.1 million by 2034. Over the assessment period, demand for fibrinogen testing is projected to grow at 8.9% CAGR.
Fibrinogen testing is becoming an ideal medical procedure/blood test to measure the fibrinogen level in blood. Its importance and demand are rising rapidly due to growing prevalence of hematological disorders and cardiovascular diseases, and the trend is expected to continue through 2034.
Fibrinogen testing is mostly employed for monitoring liver function and assessing cardiovascular diseases and blood clotting disorders. Hence, rise in cases of these diseases will directly uplift fibrinogen testing demand and boost sales of fibrinogen testing kits over the forecast period.
Medical professionals use different fibrinogen testing methods to measure fibrinogen levels. Among these, clauss method and immunologic assays, including nephelometry and enzyme-linked immunosorbent assay (ELISA), are highly popular and effective.
Fibrinogen testing is critical in measuring and monitoring low and high fibrinogen in pregnancy. This application of fibrinogen testing will further support expansion of the target industry.
| Report Attributes | Details |
|---|---|
| Estimated Market Value (2024E) | US$ 209.7 million |
| Projected Market Size (2034F) | US$ 493.1 million |
| Global Market Growth Rate (2024 to 2034) | 8.9% CAGR |
| End-stage Liver Disease Segment Market Share (2034) | 29.9% |
| Hospitals Growth Rate (2024 to 2034) | 9.4% |
| North America Market Share (2034) | 21.8% |
| East Asia Market Share (2034) | 21.8% |
| Key Companies Profiled | Siemens Healthcare GmbH; Grifols; Thermo Fisher Scientific Inc.; Stago; Helena Laboratories Corporation; Tulip Diagnostics (P) Ltd.; Werfen; Technoclone; Biosystems S.A.; Medirox AB; Randox Laboratories Ltd.; Kamiya Biomedical Company; Pathway Diagnostics Limited; MedTest; Enzyme Research Laboratories (r2 Diagnostics) |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Fibrinogen Testing Market Analysis:
Which Factors are Fueling Fibrinogen Testing Demand?
“Growing Prevalence of Blood Clotting Disorders”
In the last few years, there has been a sharp surge in cases of blood disorders. For instance, an estimated 347,026 people suffered from bleeding disorders globally in 2020, as per the World Federation of Hemophilia (WFH). This is expected to propel demand for fibrinogen testing.
Fibrinogen testing is necessary for diagnosing and monitoring blood disorders such as von Willebrand disease, disseminated intravascular coagulation, and hemophilia. Hence, rising cases of blood clotting disorders, including both thrombotic and bleeding conditions, will likely boost the fibrinogen testing market growth.
People, especially across nations like India and China, are becoming aware of bleeding disorders and the importance of early diagnosis. This can positively impact overall sales of fibrinogen testing instruments and reagents.
“High Adoption of Automated Coagulation Instruments”
The market is also witnessing high adoption of automated coagulation instruments in response to growing demand for spontaneous testing and quicker results. This is anticipated to facilitate expansion of the global fibrinogen testing industry during the assessment period.
Top companies are focusing on introducing advanced coagulation analyzers with enhanced features. Similarly, new fibrinogen testing kits are being launched in the market to meet evolving needs of end users. This will bode well for the market.
What are the Key Fibrinogen Testing Market Trends?
“Advancements in Fibrinogen Testing Technologies and Rise of Preventive Healthcare”
As the importance of fibrinogen testing continues to rise, key players are diverting their attention towards developing faster, more accurate, and POC fibrinogen testing devices. These new fibrinogen testing solutions enable quicker diagnosis and treatment decisions, thereby encouraging their adoption and fueling their demand.
Several companies are also integrating fibrinogen testing into multiplex panels alongside other coagulation tests to enhance overall patient assessment. This will further boost the coagulation testing market during the assessment period.
Rising focus on preventive healthcare and early disease detection is anticipated to propel fibrinogen testing demand. Subsequently, increasing trend toward personalized medicine will likely create growth opportunities for fibrinogen testing kit manufacturers.
Which Factors are Limiting Market Expansion?
“Low Awareness and High Equipment Costs”
Despite a strong growth trajectory, certain factors are expected to limit expansion of the target market. These include high cost of fibrinogen testing equipment. Modern testing equipment are integrated with advanced technologies, which significantly increase their prices. As a result, many end users are hesitant to purchase them.
Another factor limiting market growth is the lack of awareness across several developing and developed regions. People in certain areas know little about bleeding disorders, their diagnosis, and treatments. This can negatively impact the overall market performance.
Country-wise Insights
When it comes to market dominance, North America and East Asia are becoming top contenders. Both regions are expected to attain the exact valuation of around US$ 107 million by 2034. This is due to thriving healthcare industry in these regions, growing prevalence of blood disorders, and availability of advanced diagnostic technologies and blood testing services.
The East Asia fibrinogen testing market is set to grow with a robust CAGR of 10.0% through 2034. On the other hand, the North America fibrinogen testing industry will register a CAGR of 8.3%. Despite this variation in CAGRs, these two regions will end up with the same market share of 21.8% by the end of the forecast period.
Nations like India, Korea, Japan, and China are becoming highly lucrative markets for fibrinogen testing companies. For instance, a strong growth trajectory has been predicted for the fibrinogen testing market in India for the assessment period.
What is the United States Fibrinogen Testing Market Forecast?
“Rising Incidence of Cardiovascular Disorders Propelling Demand in the United States”
The United States fibrinogen testing market is projected to reach US$ 78 million by the end of 2034. Overall demand for fibrinogen testing in the United States is set to rise at a healthy CAGR of 8.4% during the assessment period.
Several factors are expected to spur growth in the United States fibrinogen testing industry. These include increasing prevalence of chronic diseases, high adoption of point-of-care (POC) testing devices, and strong presence of leading fibrinogen testing kit manufacturers.
The United States is witnessing a spike in cases of cardiovascular diseases like heart failure and atrial fibrillation due to changing lifestyle and eating habits, excessive smoking, and other factors. This is expected to create a high need for fibrinogen testing for risk disease assessment and management.
Another prominent factor increasing the United States fibrinogen testing market share is the rising popularity of point-of-care testing (POCT). As POCT allows for convenient and rapid testing in different settings, it is gaining wider traction in the United States. This will contribute to increasing fibrinogen testing demand.
The United States is home to several leading diagnostic companies, fibrinogen testing equipment manufacturers, and research institutes. These players are striving to develop more sensitive and specific fibrinogen assays to meet end user demand.
Researchers are also concentrating on exploring novel biomarkers to enhance the predictive value and accuracy of fibrinogen tests. Similarly, role of fibrinogen concentrate is being closely monitored in disease management. This will bode well for the target market.
Why is Japan Becoming a Highly Lucrative Market for Fibrinogen Testing in East Asia?
“Increasing Geriatric Population Making Japan a Highly Lucrative Market”
Japan fibrinogen testing market value is projected to total US$ 43.0 million by 2034. Over the assessment period, sales of fibrinogen testing reagents are anticipated to rise at a CAGR of 10.1%. This can be attributed to rising geriatric population, increasing cases of hematologic disorder, and adoption of advanced coagulation instruments and reagents.
The rapidly growing geriatric population in Japan has a profound impact on the fibrinogen testing demand. As per age, chances of age-related health conditions associated with abnormal fibrinogen levels, such as sepsis and liver disease, increase significantly. This creates demand for fibrinogen testing for diagnosis and monitoring.
Patients in Japan are also showing an inclination towards personalized medicine. This will further propel demand for fibrinogen testing as it provides valuable insights for personalized management of chronic diseases and targeted therapies.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Category-wise Insights:
The below section offers profound insights into top segments and their respective shares in the market. Based on indication, the end-stage liver disease segment is set to grow at a higher CAGR of 9.2% through 2034. By end user, hospitals segment will dominate the market with an expected share of 47.9% in 2034.
Which Indication Segment will Generate Significant Growth Opportunities for the Market?
“End-stage Liver Disease to Create Lucrative Growth Prospects for the Market”
Based on indication, end-stage liver disease segment is expected to lead the global industry during the forecast period. It will likely grow at a CAGR of around 9.2% through 2034, contributing a revenue share of 29.9%.
Increasing incidence of end-stage liver disease (ESLD) is a prominent factor driving demand for fibrinogen testing. Similarly, growing importance of fibrinogen testing in monitoring liver function will benefit the segment.
Fibrinogen testing has become a vital tool in managing end-stage liver disease, especially cirrhosis. It helps to assess bleeding risk, guide treatment decisions (like fibrinogen replacement), and improve patient outcomes. Hence, rising cases of ESLD and the need to initiate proper treatment approaches will likely elevate fibrinogen testing demand through 2034.
Who is the Leading End User of Fibrinogen Testing Reagents and Instruments?
“Adoption of Fibrinogen Testing Reagents to Remain High in Hospitals”
Hospitals remain the leading end users of fibrinogen testing reagents and other instruments. This is attributable to increasing number of hospitals globally, rising patient footfall, and availability of advanced facilities in hospitals.
As per the latest report, the hospitals segment is projected to grow with a CAGR of 9.4% during the assessment period. By 2034, the target segment will likely hold a dominant value share of 47.9%.
Patients mostly opt for diagnostic procedures and treatment in hospitals due to low costs and availability of advanced technologies and healthcare professionals. This is expected to increase consumption of fibrinogen testing reagents across hospitals.
Competitive Landscape
Siemens Healthcare GmbH, Grifols, Thermo Fisher Scientific Inc., Stago, Helena Laboratories Corporation, Tulip Diagnostics (P) Ltd., Werfen, Technoclone, Biosystems S.A., Medirox AB, Randox Laboratories Ltd. Kamiya Biomedical Company, Pathway Diagnostics Limited, MedTest, and Enzyme Research Laboratories (r2 Diagnostics) are few of the leading manufacturers of fibrinogen kits and devices listed in the report.
Key fibrinogen testing companies are continuously launching new reagents and fibrinogen testing devices to stay ahead of the competition. They are also employing strategies like partnerships, distribution agreements, mergers, acquisitions, and collaborations.
Recent Fibrinogen Testing Market Developments :
- In 2022, qLabs FIB, a new point-of-care (POC) device, was launched by Diagnostica Stago for measuring fibrinogen levels from a single drop of whole blood.
- In December 2023, Thermo Fisher Scientific signed a distribution agreement with Aesku Group for IFS testing kits and instruments.
- In March 2023, Werfen completed the acquisition of Immucor, Inc., a leading United States-based company in the in vitro diagnostics (IVD) sector. The acquisition will help the company expand its leadership in specialized diagnostics.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Fibrinogen Testing Market Segmentation:
-
By Reagent Type :
- Q.F.A. Thrombin Kits
- Fibrinogen Kits
- Multifibren U Kits
- STA-fibrinogen Kits
- Imidazole Buffer Kits
-
By Indication :
- Congenital Fibrinogen Disorders
- Fibrinogen Storage Disease
- Hereditary fibrinogen Aα-Chain amyloidosis
- Acquired Dysfibrinogenemia
- Cryofibrinogenemia
- Disseminated Intravascular Coagulation (DIC)
- End-stage Liver Disease
-
By End User :
- Hospitals
- Clinics
- Diagnostic Laboratories
- Ambulatory Care Centers
- Academic & Research Institutes
-
By Region :
- North America
- Europe
- Latin America
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
- 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Reagent Type
- 5.1. Q.F.A. Thrombin Kits
- 5.2. Fibrinogen Kits
- 5.3. Multifibren U Kits
- 5.4. STA-fibrinogen Kits
- 5.5. Imidazole Buffer Kits
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
- 6.1. Congenital Fibrinogen Disorders
- 6.2. Fibrinogen Storage Disease
- 6.3. Hereditary Fibrinogen Aα-Chain Amyloidosis
- 6.4. Acquired Dysfibrinogenemia
- 6.5. Cryofibrinogenemia
- 6.6. Disseminated Intravascular Coagulation (DIC)
- 6.7. End-Stage Liver Disease
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
- 7.1. Hospitals
- 7.2. Clinics
- 7.3. Diagnostic Laboratories
- 7.4. Ambulatory Care Centres
- 7.5. Academics & Research Institutes
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 8.1. North America
- 8.2. Latin America
- 8.3. Western Europe
- 8.4. Eastern Europe
- 8.5. South Asia and Pacific
- 8.6. East Asia
- 8.7. Middle East and Africa
- 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 16. Key Countries Market Analysis
- 17. Market Structure Analysis
- 18. Competition Analysis
- 18.1. Thermo Fisher Scientific Inc.
- 18.2. Grifols
- 18.3. Helena Laboratories Corporation
- 18.4. Stago
- 18.5. TULIP DIAGNOSTICS (P) LTD
- 18.6. Werfen
- 18.7. Biosystems S.A.
- 18.8. Randox Laboratories Ltd.
- 18.9. Kamiya Biomedical Company
- 18.10. Pathway Diagnostics Limited
- 19. Assumptions & Acronyms Used
- 20. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ million) Forecast by Region, 2019 to 2034
Table 02: Global Market Volume (Units) Forecast by Region, 2019 to 2034
Table 03: Global Market Value (US$ million) Forecast by Reagent Type, 2019 to 2034
Table 04: Global Market Volume (Units) Forecast by Reagent Type, 2019 to 2034
Table 05: Global Market Value (US$ million) Forecast by Indication, 2019 to 2034
Table 06: Global Market Volume (Units) Forecast by Indication, 2019 to 2034
Table 07: Global Market Value (US$ million) Forecast by End User, 2019 to 2034
Table 08: Global Market Volume (Units) Forecast by End User, 2019 to 2034
Table 09: North America Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 10: North America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 11: North America Market Value (US$ million) Forecast by Reagent Type, 2019 to 2034
Table 12: North America Market Volume (Units) Forecast by Reagent Type, 2019 to 2034
Table 13: North America Market Value (US$ million) Forecast by Indication, 2019 to 2034
Table 14: North America Market Volume (Units) Forecast by Indication, 2019 to 2034
Table 15: North America Market Value (US$ million) Forecast by End User, 2019 to 2034
Table 16: North America Market Volume (Units) Forecast by End User, 2019 to 2034
Table 17: Latin America Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 18: Latin America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 19: Latin America Market Value (US$ million) Forecast by Reagent Type, 2019 to 2034
Table 20: Latin America Market Volume (Units) Forecast by Reagent Type, 2019 to 2034
Table 21: Latin America Market Value (US$ million) Forecast by Indication, 2019 to 2034
Table 22: Latin America Market Volume (Units) Forecast by Indication, 2019 to 2034
Table 23: Latin America Market Value (US$ million) Forecast by End User, 2019 to 2034
Table 24: Latin America Market Volume (Units) Forecast by End User, 2019 to 2034
Table 25: Western Europe Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 26: Western Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 27: Western Europe Market Value (US$ million) Forecast by Reagent Type, 2019 to 2034
Table 28: Western Europe Market Volume (Units) Forecast by Reagent Type, 2019 to 2034
Table 29: Western Europe Market Value (US$ million) Forecast by Indication, 2019 to 2034
Table 30: Western Europe Market Volume (Units) Forecast by Indication, 2019 to 2034
Table 31: Western Europe Market Value (US$ million) Forecast by End User, 2019 to 2034
Table 32: Western Europe Market Volume (Units) Forecast by End User, 2019 to 2034
Table 33: Eastern Europe Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 34: Eastern Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 35: Eastern Europe Market Value (US$ million) Forecast by Reagent Type, 2019 to 2034
Table 36: Eastern Europe Market Volume (Units) Forecast by Reagent Type, 2019 to 2034
Table 37: Eastern Europe Market Value (US$ million) Forecast by Indication, 2019 to 2034
Table 38: Eastern Europe Market Volume (Units) Forecast by Indication, 2019 to 2034
Table 39: Eastern Europe Market Value (US$ million) Forecast by End User, 2019 to 2034
Table 40: Eastern Europe Market Volume (Units) Forecast by End User, 2019 to 2034
Table 41: South Asia and Pacific Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 42: South Asia and Pacific Market Volume (Units) Forecast by Country, 2019 to 2034
Table 43: South Asia and Pacific Market Value (US$ million) Forecast by Reagent Type, 2019 to 2034
Table 44: South Asia and Pacific Market Volume (Units) Forecast by Reagent Type, 2019 to 2034
Table 45: South Asia and Pacific Market Value (US$ million) Forecast by Indication, 2019 to 2034
Table 46: South Asia and Pacific Market Volume (Units) Forecast by Indication, 2019 to 2034
Table 47: South Asia and Pacific Market Value (US$ million) Forecast by End User, 2019 to 2034
Table 48: South Asia and Pacific Market Volume (Units) Forecast by End User, 2019 to 2034
Table 49: East Asia Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 50: East Asia Market Volume (Units) Forecast by Country, 2019 to 2034
Table 51: East Asia Market Value (US$ million) Forecast by Reagent Type, 2019 to 2034
Table 52: East Asia Market Volume (Units) Forecast by Reagent Type, 2019 to 2034
Table 53: East Asia Market Value (US$ million) Forecast by Indication, 2019 to 2034
Table 54: East Asia Market Volume (Units) Forecast by Indication, 2019 to 2034
Table 55: East Asia Market Value (US$ million) Forecast by End User, 2019 to 2034
Table 56: East Asia Market Volume (Units) Forecast by End User, 2019 to 2034
Table 57: Middle East and Africa Market Value (US$ million) Forecast by Country, 2019 to 2034
Table 58: Middle East and Africa Market Volume (Units) Forecast by Country, 2019 to 2034
Table 59: Middle East and Africa Market Value (US$ million) Forecast by Reagent Type, 2019 to 2034
Table 60: Middle East and Africa Market Volume (Units) Forecast by Reagent Type, 2019 to 2034
Table 61: Middle East and Africa Market Value (US$ million) Forecast by Indication, 2019 to 2034
Table 62: Middle East and Africa Market Volume (Units) Forecast by Indication, 2019 to 2034
Table 63: Middle East and Africa Market Value (US$ million) Forecast by End User, 2019 to 2034
Table 64: Middle East and Africa Market Volume (Units) Forecast by End User, 2019 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ million) by Reagent Type, 2024 to 2034
Figure 02: Global Market Value (US$ million) by Indication, 2024 to 2034
Figure 03: Global Market Value (US$ million) by End User, 2024 to 2034
Figure 04: Global Market Value (US$ million) by Region, 2024 to 2034
Figure 05: Global Market Value (US$ million) Analysis by Region, 2019 to 2034
Figure 06: Global Market Volume (Units) Analysis by Region, 2019 to 2034
Figure 07: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 08: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 09: Global Market Value (US$ million) Analysis by Reagent Type, 2019 to 2034
Figure 10: Global Market Volume (Units) Analysis by Reagent Type, 2019 to 2034
Figure 11: Global Market Value Share (%) and BPS Analysis by Reagent Type, 2024 to 2034
Figure 12: Global Market Y-o-Y Growth (%) Projections by Reagent Type, 2024 to 2034
Figure 13: Global Market Value (US$ million) Analysis by Indication, 2019 to 2034
Figure 14: Global Market Volume (Units) Analysis by Indication, 2019 to 2034
Figure 15: Global Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034
Figure 16: Global Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034
Figure 17: Global Market Value (US$ million) Analysis by End User, 2019 to 2034
Figure 18: Global Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 21: Global Market Attractiveness by Reagent Type, 2024 to 2034
Figure 22: Global Market Attractiveness by Indication, 2024 to 2034
Figure 23: Global Market Attractiveness by End User, 2024 to 2034
Figure 24: Global Market Attractiveness by Region, 2024 to 2034
Figure 25: North America Market Value (US$ million) by Reagent Type, 2024 to 2034
Figure 26: North America Market Value (US$ million) by Indication, 2024 to 2034
Figure 27: North America Market Value (US$ million) by End User, 2024 to 2034
Figure 28: North America Market Value (US$ million) by Country, 2024 to 2034
Figure 29: North America Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 30: North America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 31: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 32: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 33: North America Market Value (US$ million) Analysis by Reagent Type, 2019 to 2034
Figure 34: North America Market Volume (Units) Analysis by Reagent Type, 2019 to 2034
Figure 35: North America Market Value Share (%) and BPS Analysis by Reagent Type, 2024 to 2034
Figure 36: North America Market Y-o-Y Growth (%) Projections by Reagent Type, 2024 to 2034
Figure 37: North America Market Value (US$ million) Analysis by Indication, 2019 to 2034
Figure 38: North America Market Volume (Units) Analysis by Indication, 2019 to 2034
Figure 39: North America Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034
Figure 40: North America Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034
Figure 41: North America Market Value (US$ million) Analysis by End User, 2019 to 2034
Figure 42: North America Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 43: North America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 44: North America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 45: North America Market Attractiveness by Reagent Type, 2024 to 2034
Figure 46: North America Market Attractiveness by Indication, 2024 to 2034
Figure 47: North America Market Attractiveness by End User, 2024 to 2034
Figure 48: North America Market Attractiveness by Country, 2024 to 2034
Figure 49: Latin America Market Value (US$ million) by Reagent Type, 2024 to 2034
Figure 50: Latin America Market Value (US$ million) by Indication, 2024 to 2034
Figure 51: Latin America Market Value (US$ million) by End User, 2024 to 2034
Figure 52: Latin America Market Value (US$ million) by Country, 2024 to 2034
Figure 53: Latin America Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 54: Latin America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 55: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 57: Latin America Market Value (US$ million) Analysis by Reagent Type, 2019 to 2034
Figure 58: Latin America Market Volume (Units) Analysis by Reagent Type, 2019 to 2034
Figure 59: Latin America Market Value Share (%) and BPS Analysis by Reagent Type, 2024 to 2034
Figure 60: Latin America Market Y-o-Y Growth (%) Projections by Reagent Type, 2024 to 2034
Figure 61: Latin America Market Value (US$ million) Analysis by Indication, 2019 to 2034
Figure 62: Latin America Market Volume (Units) Analysis by Indication, 2019 to 2034
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034
Figure 65: Latin America Market Value (US$ million) Analysis by End User, 2019 to 2034
Figure 66: Latin America Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 67: Latin America Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 68: Latin America Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 69: Latin America Market Attractiveness by Reagent Type, 2024 to 2034
Figure 70: Latin America Market Attractiveness by Indication, 2024 to 2034
Figure 71: Latin America Market Attractiveness by End User, 2024 to 2034
Figure 72: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 73: Western Europe Market Value (US$ million) by Reagent Type, 2024 to 2034
Figure 74: Western Europe Market Value (US$ million) by Indication, 2024 to 2034
Figure 75: Western Europe Market Value (US$ million) by End User, 2024 to 2034
Figure 76: Western Europe Market Value (US$ million) by Country, 2024 to 2034
Figure 77: Western Europe Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 78: Western Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 79: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 80: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 81: Western Europe Market Value (US$ million) Analysis by Reagent Type, 2019 to 2034
Figure 82: Western Europe Market Volume (Units) Analysis by Reagent Type, 2019 to 2034
Figure 83: Western Europe Market Value Share (%) and BPS Analysis by Reagent Type, 2024 to 2034
Figure 84: Western Europe Market Y-o-Y Growth (%) Projections by Reagent Type, 2024 to 2034
Figure 85: Western Europe Market Value (US$ million) Analysis by Indication, 2019 to 2034
Figure 86: Western Europe Market Volume (Units) Analysis by Indication, 2019 to 2034
Figure 87: Western Europe Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034
Figure 88: Western Europe Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034
Figure 89: Western Europe Market Value (US$ million) Analysis by End User, 2019 to 2034
Figure 90: Western Europe Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 91: Western Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 93: Western Europe Market Attractiveness by Reagent Type, 2024 to 2034
Figure 94: Western Europe Market Attractiveness by Indication, 2024 to 2034
Figure 95: Western Europe Market Attractiveness by End User, 2024 to 2034
Figure 96: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 97: Eastern Europe Market Value (US$ million) by Reagent Type, 2024 to 2034
Figure 98: Eastern Europe Market Value (US$ million) by Indication, 2024 to 2034
Figure 99: Eastern Europe Market Value (US$ million) by End User, 2024 to 2034
Figure 100: Eastern Europe Market Value (US$ million) by Country, 2024 to 2034
Figure 101: Eastern Europe Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 102: Eastern Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 103: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 104: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 105: Eastern Europe Market Value (US$ million) Analysis by Reagent Type, 2019 to 2034
Figure 106: Eastern Europe Market Volume (Units) Analysis by Reagent Type, 2019 to 2034
Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Reagent Type, 2024 to 2034
Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Reagent Type, 2024 to 2034
Figure 109: Eastern Europe Market Value (US$ million) Analysis by Indication, 2019 to 2034
Figure 110: Eastern Europe Market Volume (Units) Analysis by Indication, 2019 to 2034
Figure 111: Eastern Europe Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034
Figure 112: Eastern Europe Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034
Figure 113: Eastern Europe Market Value (US$ million) Analysis by End User, 2019 to 2034
Figure 114: Eastern Europe Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 115: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 116: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 117: Eastern Europe Market Attractiveness by Reagent Type, 2024 to 2034
Figure 118: Eastern Europe Market Attractiveness by Indication, 2024 to 2034
Figure 119: Eastern Europe Market Attractiveness by End User, 2024 to 2034
Figure 120: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 121: South Asia and Pacific Market Value (US$ million) by Reagent Type, 2024 to 2034
Figure 122: South Asia and Pacific Market Value (US$ million) by Indication, 2024 to 2034
Figure 123: South Asia and Pacific Market Value (US$ million) by End User, 2024 to 2034
Figure 124: South Asia and Pacific Market Value (US$ million) by Country, 2024 to 2034
Figure 125: South Asia and Pacific Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 126: South Asia and Pacific Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 127: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 128: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 129: South Asia and Pacific Market Value (US$ million) Analysis by Reagent Type, 2019 to 2034
Figure 130: South Asia and Pacific Market Volume (Units) Analysis by Reagent Type, 2019 to 2034
Figure 131: South Asia and Pacific Market Value Share (%) and BPS Analysis by Reagent Type, 2024 to 2034
Figure 132: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Reagent Type, 2024 to 2034
Figure 133: South Asia and Pacific Market Value (US$ million) Analysis by Indication, 2019 to 2034
Figure 134: South Asia and Pacific Market Volume (Units) Analysis by Indication, 2019 to 2034
Figure 135: South Asia and Pacific Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034
Figure 136: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034
Figure 137: South Asia and Pacific Market Value (US$ million) Analysis by End User, 2019 to 2034
Figure 138: South Asia and Pacific Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 139: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 140: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 141: South Asia and Pacific Market Attractiveness by Reagent Type, 2024 to 2034
Figure 142: South Asia and Pacific Market Attractiveness by Indication, 2024 to 2034
Figure 143: South Asia and Pacific Market Attractiveness by End User, 2024 to 2034
Figure 144: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 145: East Asia Market Value (US$ million) by Reagent Type, 2024 to 2034
Figure 146: East Asia Market Value (US$ million) by Indication, 2024 to 2034
Figure 147: East Asia Market Value (US$ million) by End User, 2024 to 2034
Figure 148: East Asia Market Value (US$ million) by Country, 2024 to 2034
Figure 149: East Asia Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 150: East Asia Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 151: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 152: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 153: East Asia Market Value (US$ million) Analysis by Reagent Type, 2019 to 2034
Figure 154: East Asia Market Volume (Units) Analysis by Reagent Type, 2019 to 2034
Figure 155: East Asia Market Value Share (%) and BPS Analysis by Reagent Type, 2024 to 2034
Figure 156: East Asia Market Y-o-Y Growth (%) Projections by Reagent Type, 2024 to 2034
Figure 157: East Asia Market Value (US$ million) Analysis by Indication, 2019 to 2034
Figure 158: East Asia Market Volume (Units) Analysis by Indication, 2019 to 2034
Figure 159: East Asia Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034
Figure 160: East Asia Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034
Figure 161: East Asia Market Value (US$ million) Analysis by End User, 2019 to 2034
Figure 162: East Asia Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 163: East Asia Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 164: East Asia Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 165: East Asia Market Attractiveness by Reagent Type, 2024 to 2034
Figure 166: East Asia Market Attractiveness by Indication, 2024 to 2034
Figure 167: East Asia Market Attractiveness by End User, 2024 to 2034
Figure 168: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 169: Middle East and Africa Market Value (US$ million) by Reagent Type, 2024 to 2034
Figure 170: Middle East and Africa Market Value (US$ million) by Indication, 2024 to 2034
Figure 171: Middle East and Africa Market Value (US$ million) by End User, 2024 to 2034
Figure 172: Middle East and Africa Market Value (US$ million) by Country, 2024 to 2034
Figure 173: Middle East and Africa Market Value (US$ million) Analysis by Country, 2019 to 2034
Figure 174: Middle East and Africa Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 175: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 176: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 177: Middle East and Africa Market Value (US$ million) Analysis by Reagent Type, 2019 to 2034
Figure 178: Middle East and Africa Market Volume (Units) Analysis by Reagent Type, 2019 to 2034
Figure 179: Middle East and Africa Market Value Share (%) and BPS Analysis by Reagent Type, 2024 to 2034
Figure 180: Middle East and Africa Market Y-o-Y Growth (%) Projections by Reagent Type, 2024 to 2034
Figure 181: Middle East and Africa Market Value (US$ million) Analysis by Indication, 2019 to 2034
Figure 182: Middle East and Africa Market Volume (Units) Analysis by Indication, 2019 to 2034
Figure 183: Middle East and Africa Market Value Share (%) and BPS Analysis by Indication, 2024 to 2034
Figure 184: Middle East and Africa Market Y-o-Y Growth (%) Projections by Indication, 2024 to 2034
Figure 185: Middle East and Africa Market Value (US$ million) Analysis by End User, 2019 to 2034
Figure 186: Middle East and Africa Market Volume (Units) Analysis by End User, 2019 to 2034
Figure 187: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 188: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 189: Middle East and Africa Market Attractiveness by Reagent Type, 2024 to 2034
Figure 190: Middle East and Africa Market Attractiveness by Indication, 2024 to 2034
Figure 191: Middle East and Africa Market Attractiveness by End User, 2024 to 2034
Figure 192: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the fibrinogen testing market?
The fibrinogen testing market is estimated to total US$ 209.7 million in 2024.
What is the demand outlook for fibrinogen testing?
Global fibrinogen testing demand is projected to grow at 8.9% CAGR through 2034.
What is the projected market size in 2034?
The fibrinogen testing market is anticipated to reach US$ 493.1 million in 2034.
What is the demand outlook for the North America market?
Demand in North America is expected to increase at 8.3% CAGR through 2034.
What is the growth projection for the Korea fibrinogen testing market?
South Korea is set to register a CAGR of 10.4% CAGR.
What is the method of fibrinogen test?
Clauss fibrinogen assay is a widely used laboratory method for measuring fibrinogen.
How much does a fibrinogen test cost?
Fibrinogen test costs around 500 to 1700 in India.
What is the fibrinogen blood test for?
It is used to measure fibrinogen levels in blood.
Fibrinogen Testing Market